Venture Leaders 2019 Teams Celebrated at the US Embassy in Switzerland
On November 25th, 2019, the United States Embassy in Switzerland hosted a unique event for the Swiss entrepreneurship ecosystem: The Venture Leaders graduation ceremony. The two teams of Venture Leaders Technology and Life Sciences were celebrated at the embassy after their successful roadshows respectively in Silicon Valley and in Boston – an event reflecting on the ties between Switzerland and the United States while showcasing Switzerland as a breading-ground for disrupting technologies.
Hosted by the Deputy Chief of Mission Eva Weigold Schultz at the US Ambassador's residence in Bern, the Venture Leaders 2019 teams gave a short pitch highlighting the impact of their american roadshow before receiving the Venture Leaders diploma.
The two teams went through the program comprising the kick-off to prepare for the Roadshow, the Startup champions events in Switzerland where they pitched to the Swiss startup community and then went for a full week exposure to US business and Venture Capital scene.
First to travel in March of this year, the Venture Leaders Technology team expeirenced and exceptional week of business acceleratino through meetings with top notch investors and industry leaders. Proudly showcasing Switzerland as a deep tech nation:
9TLABS, Agrosustain, ElectricFeel, Maptiler, Microcaps, Mirrakoi, Mobbot, Qnami,
Seervision, WECHEER , below at the graduation with the Deputy Chief of Mission.
(2).jpg)
"Our mission was to conquer to the U.S and seduce local VC's. One of the key benefit of the program was to get the support of an entire team of super motivated Swiss entrepreneurs. This experience got us to the next level in terms of pitching and networking skills." said Matthieu Munsch, CEO and co-founder of Qnami, a quantum microscope-maker startup which recently raised CHF 2.6m to enter magnetic imaging market.
The Venture Leaders Life Sciences team first pitch at the Startup Champion Seed Night at EPFL in April , before dive in the Boston VC ecosystem in June.
4D Lifetec, Juvabis , Medyria , Pattern Biosciences, Positrigo , Resistell , Scailyte , Synendos Therapeutics , Tolremo Therapeutics , Volumina Medical, below with the deputy Chief of Mission.
.jpg)
The event marked the conclusion of their incredible adventures in the US entrepreneurial ecosystem and was the opportunity recognize their success and contribution to the economy. An evening to remember for our Swiss entrepreneurs.
Relive the journey of our Venture Leaders in the different American innovation hubs with the reports of our team captains:
- A Week in Silicon Valley: a Word from the Venture Leaders Technology Team Captain
- A few lessons and thoughts from the Venture Leaders Life Sciences roadshow in Boston, 9-15 June 2019 by Danuta Cichocka
4D Lifetec AG: Liquid Biopsy Assay for early cancer detection
4D Lifetec AG is the pioneering company in non-genomic, immuno-oncologic blood assays for early cancer diagnostic. Due to its proprietary transformational DDS biomarker, 4D Lifetest™ has several possi... Read more
Juvabis AG: Next generation of antibacterial therapeutics
Juvabis is a clinical-stage biopharmaceutical startup that develops next-generation antimicrobial therapeutics against highly drug resistant infections. Juvabis holds an exclusive worldwide license fo... Read more
Medyria AG: Advanced and intuitive methods for the visualization and con
Medyria has developed a unique technology for the direct measurement of the Blood Flow Velocity (BFV) and is developing medical devices that integrates the BFV sensor. Recently we started the develop... Read more
Pattern BioSciences AG: Pattern BioSciences uses gene circuit technology to design programmable gene therapies
Pattern BioSciences is an early stage biotechnology start up company and an ETH Zurich spin-off. The company develops programmable cancer gene therapies using gene circuit technologies. Read more
Positrigo AG: Cost-effective functional brain imaging for everyone
Positrigo's vision is to image everyone. Offering innovative solutions for providing functional brain positron emission tomography scans to the masses, our first focus is the early detection of Alzhei... Read more
Resistell AG: Revolutionary alternative for antibiotic susceptibility test
Resistell is revolutionizing Antibiotic Susceptibility Testing (AST) with the world’s fastest platform. Our CE IVD-certified AST for bloodstream infections has been validated in two clinical studies w... Read more
Scailyte AG: Predictive biomarkers, fueling next-gen pharma pipelines.
Scailyte pioneers single-cell biomarker discovery as this technology enters clinical trials. Our proprietary computational platform creates high-value IP and clinical assets in autoimmunity and oncolo... Read more
Synendos Therapeutics AG: Developing therapies for neuropsychiatric disorders.
Synendos is a clinical stage neuroscience company developing breakthrough safe and effective therapies for neuropsychiatric disorders such as PTSD, through modulation of a new drug target that enables... Read more
TOLREMO therapeutics AG: Development of resistance-breaking cancer therapies
TOLREMO therapeutics' mission is to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies. Led by phenotypic insights, we discovered a pivotal mechanism ... Read more
Volumina Medical SA: Dynamic biomaterials for reconstructive and plastic surgery
Volumina is a clinical stage medtech start-up, spin off of EPFL. We are active in the field of tissue engineering and develops Adipearl, an injectable biomaterial for the reconstruction of volumes o... Read more
